This page has been updated with FAQs regarding the FDA LDT proposal and ASM's planned response. Thanks Paige M.K. Larkin, PhD, D(ABMM) Mary Lee Watts and ASM

Here is the formal response from ASM to the FDA LDT proposal. Thanks to the members of our community who helped generate the data and contributed to this document. asm.org/Articles/Polic…

Speakers’ dinner for EasternPABranchASM Clinical Symposium was fantastic. Ready to hear great talks from David Gaston Rebecca Yee, PhD, D(ABMM) @SundermannAJ Linoj Samuel. PhD, D(ABMM) @court_comar and more! Thanks to all the sponsors for supporting #EPAASM23

A genuine pleasure to speak at such an excellent meeting. The content and organization was amazing Kyle G. Rodino, PhD, D(ABMM), MLS(ASCP) EasternPABranchASM

Thought Leadership, Networking, Branding, and Advertising Opportunities to maximize your company's exposure at #PASCV2024 May 17-18 in Clearwater Beach, FL! Explore more here: cdn.ymaws.com/www.pascv.org/…

When your Maldi manufacturer & most of the field of #clinicalmicrobiology doesn’t realize that there’s no “official taxonomy” for bacteria and that the “old name” can still be used so long as it’s validly published ⁦Sheila Patrick⁩ ⁦Linoj Samuel. PhD, D(ABMM)⁩

Register here for our first virtual ASM Clinical Microbiology and Public Health (CPHM) Virtual Business meeting. Updates on ASM advocacy and CPHM related topics. A chance to get engaged and informed ASM pathlms.com/asm/courses/57…

Credit to Melissa Miller for taking the lead on this article. Unfortunately the FDA note from yesterday indicates that they are not taking this feedback into consideration fda.gov/medical-device…

Measles is a bad actor, I worked with Bill Marsh The New York Times we graphically represented what happens when 10,000 kids contract measles including 2,000 hospitalizations also permanent injuries or even death from virus VS the minuscule, pinprick side effects of vaccines: No Contest

Laboratory Developed Tests (LDTs) fill a critical diagnostic testing gap for pathogens impacting underserved and higher risk patient populations; they are essential for promoting laboratory equity. Learn more in our recent article on LDTs. asm.social/1Hu

asm.org/Articles/Polic…

As we come to the end of #labweek 2024 remember that investing in clinical lab personnel isn't something you wait to do when the next pandemic rolls around but can have an incredibly positive impact on the quality of patient care today #clinicalmicro ASM

#Chagas, #Leishmaniasis, #Malaria, and counting... this will only accentuate the gap in testing for NYDs in the US #LDTsforNTDs Infectious Diseases Outbreak News Today GlobalVectorHub Paige M.K. Larkin, PhD, D(ABMM) Linoj Samuel. PhD, D(ABMM) ASM IDSA ACE ASTMH ASP-Parasitologists journals.plos.org/plosntds/artic…

Register now and join ASM on June 3 for an online town hall on the FDA's final rule on laboratory-developed test (LDT) regulation. Available for ASM members ASM pathlms.com/asm/courses/69…

Anthony Tran's career is underscored by a deep commitment to improving public health. From consulting on global public health initiatives to navigating infectious disease outbreaks and promoting food safety, his focus is steadfast on making a broad impact. asm.social/1TH

Kudos to the ASM Clinical Micro and Public Health PS&W subcommittee lead by @DienBard and Kyle G. Rodino, PhD, D(ABMM), MLS(ASCP) for the first ever paper demonstrating the value of medical microbiology consults on patient care in the US pubmed.ncbi.nlm.nih.gov/38904385/

Congratulations to our own Geehan Suleyman on her contribution to the (newly released!) blood culture diagnostic stewardship guidelines from ASM Linoj Samuel. PhD, D(ABMM) SHEA IDSA Henry Ford Health asm.org/guideline/bloo…

Great to see the Larson Middle School Omegabots robotics team highlighted in this The Troy Times article Larson Middle School TroySchools candgnews.com/news/larson-om…